To view this email as a web page, click here.
November 16, 2017
 
Vascular anomalies require team approach
Patients with vascular anomalies benefit from multidisciplinary treatment often involving propranolol and/or sirolimus. Learn more.
 
Sirolimus may reduce refractory hemangiomas
mTOR inhibitor helps child with diffuse vascular anomalies and extensive organ involvement. Learn more.
 
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.